Published in Cell Mol Biol (Noisy-le-grand) on February 16, 2009
Use of Granada medium to detect group B streptococcal colonization in pregnant women. J Clin Microbiol (1999) 1.64
A homozygous mutation in the ferrochelatase gene underlies erythropoietic protoporphyria associated with palmar keratoderma. Br J Dermatol (2009) 1.42
A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J Interferon Cytokine Res (1999) 1.38
Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol (1998) 1.23
Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol (1997) 1.13
Identification of serum and urine proteins responsible for enhanced pigment production by group B streptococci as amylases. Clin Diagn Lab Immunol (1996) 1.06
New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridization. J Pathol (2001) 0.96
Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection. Mol Ther (2001) 0.94
Two cases in infantile and familial porphyria cutanea tarda. Dermatologica (1980) 0.94
Right-sided endocarditis complicating an atrial septal defect. Am J Med Sci (2003) 0.90
Identification of a peptide from mammal albumins responsible for enhanced pigment production by group B streptococci. Clin Diagn Lab Immunol (1999) 0.89
A systematic analysis of the mutations of the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria. Eur J Hum Genet (1996) 0.88
Modification of immune response in mice by ciprofloxacin. Antimicrob Agents Chemother (1995) 0.88
Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria. Mol Ther (2001) 0.86
Pigment production by Streptococcus agalactiae in quasi-defined media. Appl Environ Microbiol (2001) 0.85
Association between aminolevulinate dehydrase genotypes and blood lead levels in children from a lead-contaminated area in Antofagasta, Chile. Arch Environ Contam Toxicol (2004) 0.85
PET imaging of thymidine kinase gene expression in the liver of non-human primates following systemic delivery of an adenoviral vector. Gene Ther (2008) 0.84
Pleomorphic adenoma of the salivary glands: prospective clinicopathologic and flow cytometric study. Head Neck (1999) 0.83
Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection. Hepatology (1998) 0.82
Porphyria cutanea tarda associated with lymphoma. J Dermatol (1984) 0.82
[Prevalence of porphyria cutanea tarda in Madrid and relationship between urine porphyrin and ethanol intake in a multiple linear regression model]. Med Clin (Barc) (1996) 0.82
How the atmosphere and the presence of substrate affect the photo and non-photoinactivation of heme enzymes by uroporphyrin I. Int J Biochem (1994) 0.81
Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma. Anticancer Res (2002) 0.80
Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis. J Infect Dis (1995) 0.78
Secretory carcinoma of the breast. Report of a case with diagnosis by fine needle aspiration. Acta Cytol (1992) 0.78
Chromosome-mediated resistance of Yersinia enterocolitica serotype O9 to intracellular killing by mouse peritoneal macrophages. FEMS Immunol Med Microbiol (1994) 0.78
Diagnostic accuracy of the cytologic diagnosis of anal human papillomavirus infection compared with DNA hybridization studies. Sex Transm Dis (1993) 0.78
Immunofluorometric assay of pepsinogen C and preliminary clinical applications. Clin Chem (1997) 0.78
Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene. Br J Dermatol (2007) 0.78
Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury. Cell Mol Biol (Noisy-le-grand) (2009) 0.77
Quantitative immunohistochemical analyses of the expression of E-cadherin, thrombomodulin, CD44H and CD44v6 in primary tumours of pharynx/larynx squamous cell carcinoma and their lymph node metastases. Anal Cell Pathol (1999) 0.77
Delta aminolevulinate dehydratase (ALA-D) activity in human and experimental diabetes mellitus. Int J Biochem Cell Biol (1999) 0.77
Mechanistic studies on uroporphyrin I-induced photoinactivation of some heme-enzymes. Int J Biochem Cell Biol (1996) 0.77
Clinical utility of fluorometric scanning of plasma porphyrins for the diagnosis and typing of porphyrias. Clin Exp Dermatol (1993) 0.77
Cell proliferation activity and kinetic profile in the prognosis and therapeutic management of carcinoma of the pharynx and larynx. Otolaryngol Head Neck Surg (1999) 0.77
Porphyrinogenic properties of the anesthetic enflurane. Gen Pharmacol (1992) 0.77
Experimental infection of mice with Yersinia enterocolitica serotype O9 by oral and parenteral routes: spreading and enterotropism of virulent yersiniae. Curr Microbiol (1999) 0.76
Hepatic acetylator phenotype in porphyria cutanea tarda. Arch Dermatol Res (1981) 0.76
The most frequent HFE allele linked to porphyria cutanea tarda in Mediterraneans is His63Asp. Hepatology (1999) 0.76
Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection. J Viral Hepat (2001) 0.76
Keratomycosis due to Scedosporium apiospermum. Mycoses (1992) 0.76
The genetic basis of porphyria cutanea tarda. Arch Dermatol Res (1985) 0.75
Heterogeneity of familial porphyria cutanea tarda. J Med Genet (1988) 0.75
Fine needle aspiration of sclerosing lymphocytic lobulitis of the breast. A report of two cases. Acta Cytol (1998) 0.75
Comparative flow cytometric analysis of DNA-bound PCNA and DNA content as estimators of S-phase cells in cell cultures. Anal Cell Pathol (1996) 0.75
[Mixed hepatoblastoma in an adult]. Rev Esp Enferm Apar Dig (1987) 0.75
[Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy]. Arch Soc Esp Oftalmol (2007) 0.75
[Abscesses of the large intestine caused by a fish bone. Considerations apropos of 3 cases]. Rev Esp Enferm Apar Dig (1980) 0.75
[Pulmonary granulomatous arteritis caused by microembolism of foreign body]. Rev Clin Esp (1978) 0.75
Hepatitis B serum markers in porphyria cutanea tarda. J Dermatol (1986) 0.75
[Porphyrin excretion in normal (author's transl)]. Rev Esp Fisiol (1980) 0.75
Ploidy analysis on Wilms' tumour touch imprints using ethidium bromide and automated image analysis integrated confocal laser scanning microscopy. Virchows Arch (1995) 0.75
[Erythropoietic protoporphyria]. Ann Dermatol Venereol (1980) 0.75
Influence of pH on the porphyrin binding to plasma proteins. Horm Metab Res (1992) 0.75
Disappearance of DNA HPV in sequential specimens of occult cervical infection in a "normal" population. Eur J Gynaecol Oncol (1996) 0.75
[Prolonged fever caused by toxoplasmosis]. Aten Primaria (1989) 0.75
Yersinia enterocolitica serotype O:3 is arthritogenic for mice. Microb Pathog (1990) 0.75
[Generalized lymphadenopathy with morphologic findings of multicentric angiofollicular ganglionic hyperplasia in a patient with AIDS]. Rev Clin Esp (1993) 0.75
[Study of liver porphyrins in patients with liver cirrhosis]. Rev Clin Esp (1977) 0.75
[Use of the Granada media and quality control of culture media]. Enferm Infecc Microbiol Clin (2000) 0.75
[Report on Spanish ophthalmology presented in the 1st Ophthalmology Congress (Brussels, 1857)]. Arch Soc Esp Oftalmol (2013) 0.75
Bullous dermatosis of hemodialysis. J Dermatol (1985) 0.75
[Asthma and hyperthyroidism: a dangerous association]. An Med Interna (1990) 0.75
Single dose treatment of vaginal candidosis: randomised comparison of amorolfine (50 mg and 100 mg) and clotrimazole (500 mg) in patients with vulvovaginal candidosis. Mycoses (1991) 0.75
Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda. Int J Biochem Cell Biol (1995) 0.75
Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cell Mol Biol (Noisy-le-grand) (2002) 0.75
Cell proliferation activity and prognostic index in squamous cell lung carcinoma. Anal Cell Pathol (1998) 0.75
[Eyeglasses in XV century Spanish art (II)]. Arch Soc Esp Oftalmol (2013) 0.75
Reference values of 5-aminolevulinate dehydrase and porphobilinogen deaminase in the Spanish population from Madrid. Ecotoxicol Environ Saf (1998) 0.75
Yersinia enterocolitica serotype 0:3-induced arthritis in mice: microbiological and histopathological information. APMIS (1992) 0.75
Long-term erythropoietin in rats with reduced renal mass. Nephron (1996) 0.75
Salivary porphyrin concentration in porphyria cutanea tarda. J Dermatol Sci (1993) 0.75
[Pleural effusion due to Parvimonas micra. A case report and a literature review of 30 cases]. Rev Esp Quimioter (2017) 0.75
[Serum BCM in patients with nontumorous diseases. Preliminary results]. Rev Clin Esp (1990) 0.75
Streptococcus agalactiae: prevention and vaccine development. Rev Esp Quimioter (2017) 0.75
[The three most important books on ophthalmology from the 20th century]. Arch Soc Esp Oftalmol (2007) 0.75
Quantitative pathology of the cervical intraepithelial neoplasia. Eur J Gynaecol Oncol (1993) 0.75
[Strongyloidiasis in an immunodepressed patient]. Rev Esp Enferm Apar Dig (1988) 0.75
Identification and characterization of HMBS gene mutations in Spanish patients with acute intermittent porphyria. Cell Mol Biol (Noisy-le-grand) (2009) 0.75
Performance of thiophilic adsorption chromatography in the purification of rat IgG2b monoclonal antibodies from serum- and protein-free culture supernatants. Biomed Chromatogr (1999) 0.75
[Prospects for gene therapy in hematology]. Ann Biol Clin (Paris) (1999) 0.75
[Several ophthalmologic references in Spanish literature in the beginning of the 20th century]. Arch Soc Esp Oftalmol (2009) 0.75
Successful treatment of haemodialysis-related porphyria cutanea tarda with erythropoietin. Nephrol Dial Transplant (1994) 0.75
[Ophthalmology in the Treatise of surgical operations by Martín Martínez]. Arch Soc Esp Oftalmol (2010) 0.75
[Street vendor glasses]. Arch Soc Esp Oftalmol (2013) 0.75
[Laparoscopic findings in chronic hepatic porphyria (author's transl)]. Leber Magen Darm (1978) 0.75
Nonsynergic effect of ethanol and lead on heme metabolism in rats. Ecotoxicol Environ Saf (1999) 0.75
[First eyeglasses in paintings and miniatures of the 14th century]. Arch Soc Esp Oftalmol (2007) 0.75
[Hepatosplenic silicosis]. Rev Clin Esp (1974) 0.75
[Laboratory approximation to the diagnosis and typification of porphyria]. An Med Interna (2000) 0.75
[Glasses in XV century Spanish art (i)]. Arch Soc Esp Oftalmol (2012) 0.75
Electroneurophysiological abnormalities in porphyria cutanea tarda. Clin Exp Dermatol (1985) 0.75
Activation of the sympathetic nervous system in hemodialyzed patients treated with erythropoietin. Nephron (1995) 0.75